$AMGN
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$AMGN
Amgen Inc.
$AMGNNASDAQHealthcareMega-Cap
Amgen is a biotechnology company that discovers, develops, and delivers innovative medicines for serious illnesses.
Market Cap
$155.0B
Revenue (TTM)
$33.4B
+22.0%
Net Income (TTM)
$6.1B
+18.0%
EPS (TTM)
$11.20
P/E Ratio
26.0
Dividend Yield
3.0%
52-Week Range
$245-$340
Beta
0.55
Dimension Scores
Fundamental
74Technical
66Sentiment
70Risk / Reward
74Momentum
66Financial Health
Profitability
79strong
Growth
69moderate
Liquidity
82strong
Solvency
76strong
Efficiency
72strong
Valuation, technical analysis, investment thesis, risk assessment and more for $AMGN
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.